BSX
Boston Scientific Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$69.10
+0.55 ▲ +0.80%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$69.73
+0.60 ▲ +0.87%
| Index | S&P 500 | P/E | 35.63 | EPS (ttm) | 1.94 | Insider Own | 0.37% | Shs Outstand | 1.48B | Perf Week | -3.15% |
| Market Cap | 102.58B | Forward P/E | 17.63 | EPS next Y | 13.02% | Insider Trans | -5.25% | Shs Float | 1.48B | Perf Month | -5.95% |
| Enterprise Value | 112.75B | PEG | 1.34 | EPS next Q | 0.79 | Inst Own | 93.57% | Short Float | 1.78% | Perf Quarter | -25.46% |
| Income | 2.90B | P/S | 5.11 | EPS this Y | 13.36% | Inst Trans | 0.1% | Short Ratio | 1.81 | Perf Half Y | -33.77% |
| Sales | 20.07B | P/B | 4.23 | EPS next 5Y | 13.19% | ROA | 6.98% | Short Interest | 26.26M | Perf YTD | -27.53% |
| Book/sh | 16.34 | P/C | 50.16 | EPS past 3/5Y | 63.23% - | ROE | 12.6% | 52W High | -36.89% ($109.50) | Perf Year | -27.55% |
| Cash/sh | 1.38 | P/FCF | 28.04 | Sales past 3/5Y | 16.54% 15.16% | ROIC | 8.09% | 52W Low | 2.28% ($67.56) | Perf 3Y | 45.17% |
| Dividend Est. | - | EV/EBITDA | 20.73 | EPS Y/Y TTM | 55.39% | Gross Margin | 65.04% | Volatility(W/M) | 3.05% 2.58% | Perf 5Y | 77.86% |
| Dividend TTM | - | EV/Sales | 5.62 | Sales Y/Y TTM | 19.88% | Oper. Margin | 20.28% | ATR (14) | 2.22 | Perf 10Y | 282.83% |
| Dividend Ex-Date | - | Quick Ratio | 1.08 | EPS Q/Q | 18.3% | Profit Margin | 14.44% | RSI (14) | 29.94 | Recom | 1.24 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.62 | Sales Q/Q | 15.9% | SMA20 | -5.92% ($73.45) | Beta | 0.73 | Target Price | $103.56 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 2000000 | SMA50 | -16.77% ($83.02) | Rel Volume | 0.8 | Prev Close | $68.55 |
| Employees | 59000 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 2.49% 0.12% | SMA200 | -28.47% ($96.6) | Avg Volume(3M) | 14.50M | Price | $69.1 |
| IPO | 1992/5/19 | Option/Short | Yes/Yes | Trades | 70195 | Volume | 11,660,822 | Change | 0.8% |
뉴스 로딩 중...